The Market Capitalization of the company stands at 510.56 Million. Your own financial situation and investment needs are what matter. It has a 56.73 P/E ratio. In early trading, the stock has dipped -5.43% on steady volume. The gap was reported on April, 18 by Barchart.com. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company. Moving average strategies are also popular and can be tailored to any time frame, suiting both long term investors and short-term traders.
Interpace Diagnostics Group Inc (NASDAQ:IDXG) shares are exploding by 91% in today's trading after the company announced that UnitedHealthcare, the largest health plan in the U.S., has agreed to cover Interpace's ThyraMIR test for thyroid cancer biopsies. It has underperformed by 75.47% the S&P500.
Investors sentiment decreased to 0.75 in 2016 Q4. Its down 0.18, from 0.93 in 2016Q3.
The biggest institutional shareholders in GNC Holdings, Inc. include Fidelity Management and Research Company which owns 10 million shares in the company valued at $108.97 million.
According to Zacks brokerage recommendations, GNC Holdings, Inc. The company is set at a mean analysts' recommendation of 2.10. Canada Pension Plan Investment Board reported 0.03% of its portfolio in GNC Holdings Inc (NYSE:GNC). Kcg Holdg has 0% invested in GNC Holdings Inc (NYSE:GNC).
Image source Getty Images
Here we discussed Analysts views what they told about GNC Holdings, Inc. Switzerland-based Credit Suisse Ag has invested 0.01% in GNC Holdings Inc (NYSE:GNC). GNC Holdings also saw some unusual options trading activity on Tuesday. Following the transaction, the senior vice president now directly owns 74,512 shares in the company, valued at $575,232.64.
Several hedge funds have recently modified their holdings of GNC. Winslow Evans & Crocker, a Massachusetts-based fund reported 5,030 shares. Thanks to the agreement, Cabela's was able to restructure its deal with Bass Pro Shops, and now, investors will get $61.50 per share in cash. The difference between the expected and actual EPS was $-0.29/share, which represents an Earnings surprise of -80.6%. The correct version of this piece can be read at https://transcriptdaily.com/2017/04/20/gnc-holdings-inc-gnc-releases-earnings-results-beats-expectations-by-0-04-eps.html. 5 have given the stock a Hold rating, 4 as Underperform and 0 as Sell. Therefore 20% are positive. Empire State Realty Trust had 4 analyst reports since September 10, 2015 according to SRatingsIntel. The company now has an average rating of "Hold" and an average target price of $17.86. Strong earnings growth is essential to a stock's success and has the greatest impact on its future price performance. The firm has "Buy" rating by Stifel Nicolaus given on Wednesday, February 24. As per Thursday, August 25, the company rating was initiated by BTIG Research. 6 advised "Hold Rating" regarding the stock. On Monday, November 2 the stock rating was maintained by Barclays Capital with "Overweight".
USA markets were dragged down by the Banking and Healthcare sectors Tuesday after Goldman Sachs and Johnson & Johnson reported earnings that fell short of expectations.
GNC Holdings, Inc.is a specialty retailer of health, wellness and performance products, including vitamins, minerals and herbal supplement products (VMHS), sports nutrition products and diet products. The analysts estimated sales for the higher end at 640.24 million and lower end at 612.8 million while the year ago reported sale was 688.29 million.
GNC Holdings reports its operations under three segments: U.S. & Canada - including company-owned stores in the U.S., Puerto Rico and Canada, franchise stores in the U.S. and e-commerce; worldwide - including franchise locations in approximately 50 countries, The Health Store and China operations; and Manufacturing/Wholesale - comprising manufactured product sold to other segments, third-party contract manufacturing and sales to wholesale partners.
Oracle acquires digital measurement company Moat
Oracle shares closed 0.52 percent higher on Tuesday's regular trading session. The financial terms of the deal were not disclosed.